| Year |
Citation |
Score |
| 2020 |
Spatola M, Pedrol MP, Maudes E, Simabukuro M, Muñiz-Castrillo S, Pinto AL, Wandinger KP, Spiegler J, Schramm P, Dutra LA, Iorio R, Kornblum C, Bien CG, Höftberger R, Leypoldt F, ... ... Rosenfeld MR, et al. Clinical features, prognostic factors, and antibody effects in anti-mGluR1 encephalitis. Neurology. PMID 32928978 DOI: 10.1212/Wnl.0000000000010854 |
0.355 |
|
| 2019 |
Dalmau J, Armangué T, Planagumà J, Radosevic M, Mannara F, Leypoldt F, Geis C, Lancaster E, Titulaer MJ, Rosenfeld MR, Graus F. An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. The Lancet. Neurology. PMID 31326280 DOI: 10.1016/S1474-4422(19)30244-3 |
0.358 |
|
| 2018 |
Blakeley JO, Grossman SA, Chi AS, Mikkelsen T, Rosenfeld MR, Ahluwalia MS, Nabors LB, Eichler A, Garcia-Ribas I, Desideri S, Ye X. Phase II Study of Iniparib with Concurrent Chemoradiation in Patients with Newly Diagnosed Glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30131387 DOI: 10.1158/1078-0432.Ccr-18-0110 |
0.304 |
|
| 2018 |
Spatola M, Sabater L, Planagumà J, Martínez-Hernandez E, Armangué T, Prüss H, Iizuka T, Caparó Oblitas RL, Antoine JC, Li R, Heaney N, Tubridy N, Munteis Olivas E, Rosenfeld MR, Graus F, et al. Encephalitis with mGluR5 antibodies: Symptoms and antibody effects. Neurology. PMID 29703767 DOI: 10.1212/Wnl.0000000000005614 |
0.372 |
|
| 2018 |
Hara M, Martinez-Hernandez E, Ariño H, Armangué T, Spatola M, Petit-Pedrol M, Saiz A, Rosenfeld MR, Graus F, Dalmau J. Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor. Neurology. PMID 29549218 DOI: 10.1212/Wnl.0000000000005329 |
0.363 |
|
| 2017 |
Hara M, Ariño H, Petit-Pedrol M, Sabater L, Titulaer MJ, Martinez-Hernandez E, Schreurs MW, Rosenfeld MR, Graus F, Dalmau J. DPPX antibody-associated encephalitis: Main syndrome and antibody effects. Neurology. PMID 28258082 DOI: 10.1212/Wnl.0000000000003796 |
0.357 |
|
| 2017 |
Spatola M, Petit-Pedrol M, Simabukuro MM, Armangue T, Castro FJ, Barcelo Artigues MI, Julià Benique MR, Benson L, Gorman M, Felipe A, Caparó Oblitas RL, Rosenfeld MR, Graus F, Dalmau J. Investigations in GABAA receptor antibody-associated encephalitis. Neurology. PMID 28202703 DOI: 10.1212/Wnl.0000000000003713 |
0.342 |
|
| 2016 |
Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, Cortese I, Dale RC, Gelfand JM, Geschwind M, Glaser CA, Honnorat J, Höftberger R, Iizuka T, Irani SR, ... ... Rosenfeld MR, et al. A clinical approach to diagnosis of autoimmune encephalitis. The Lancet. Neurology. PMID 26906964 DOI: 10.1016/S1474-4422(15)00401-9 |
0.328 |
|
| 2015 |
Armangue T, Moris G, Cantarín-Extremera V, Conde CE, Rostasy K, Erro ME, Portilla-Cuenca JC, Turón-Viñas E, Málaga I, Muñoz-Cabello B, Torres-Torres C, Llufriu S, González-Gutiérrez-Solana L, González G, Casado-Naranjo I, ... Rosenfeld M, et al. Autoimmune post-herpes simplex encephalitis of adults and teenagers. Neurology. PMID 26491084 DOI: 10.1212/Wnl.0000000000002125 |
0.381 |
|
| 2015 |
Höftberger R, Rosenfeld MR, Dalmau J. Update on neurological paraneoplastic syndromes. Current Opinion in Oncology. 27: 489-95. PMID 26335665 DOI: 10.1097/Cco.0000000000000222 |
0.304 |
|
| 2014 |
Rosenfeld MR. Antibody-mediated central nervous system diseases: disease recognition and treatment challenges. Clinical and Experimental Immunology. 178: 30-2. PMID 25546752 DOI: 10.1111/Cei.12501 |
0.423 |
|
| 2014 |
Linnoila JJ, Rosenfeld MR, Dalmau J. Neuronal surface antibody-mediated autoimmune encephalitis. Seminars in Neurology. 34: 458-66. PMID 25369441 DOI: 10.1055/S-0034-1390394 |
0.422 |
|
| 2014 |
Rosenfeld MR, Ye X, Supko JG, Desideri S, Grossman SA, Brem S, Mikkelson T, Wang D, Chang YC, Hu J, McAfee Q, Fisher J, Troxel AB, Piao S, Heitjan DF, et al. A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme. Autophagy. 10: 1359-68. PMID 24991840 DOI: 10.4161/Auto.28984 |
0.307 |
|
| 2014 |
Titulaer MJ, Höftberger R, Iizuka T, Leypoldt F, McCracken L, Cellucci T, Benson LA, Shu H, Irioka T, Hirano M, Singh G, Cobo Calvo A, Kaida K, Morales PS, Wirtz PW, ... ... Rosenfeld MR, et al. Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis. Annals of Neurology. 75: 411-28. PMID 24700511 DOI: 10.1002/Ana.24117 |
0.412 |
|
| 2014 |
Dalmau J, Rosenfeld MR. Autoimmune encephalitis update. Neuro-Oncology. 16: 771-8. PMID 24637228 DOI: 10.1093/Neuonc/Nou030 |
0.391 |
|
| 2014 |
Gresa-Arribas N, Titulaer MJ, Torrents A, Aguilar E, McCracken L, Leypoldt F, Gleichman AJ, Balice-Gordon R, Rosenfeld MR, Lynch D, Graus F, Dalmau J. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. The Lancet. Neurology. 13: 167-77. PMID 24360484 DOI: 10.1016/S1474-4422(13)70282-5 |
0.393 |
|
| 2013 |
Pruitt AA, Graus F, Rosenfeld MR. Neurological complications of transplantation: part I: hematopoietic cell transplantation. The Neurohospitalist. 3: 24-38. PMID 23983885 DOI: 10.1177/1941874412455338 |
0.301 |
|
| 2013 |
Titulaer MJ, McCracken L, Gabilondo I, Iizuka T, Kawachi I, Bataller L, Torrents A, Rosenfeld MR, Balice-Gordon R, Graus F, Dalmau J. Late-onset anti-NMDA receptor encephalitis. Neurology. 81: 1058-63. PMID 23946310 DOI: 10.1212/Wnl.0B013E3182A4A49C |
0.34 |
|
| 2013 |
Rosenfeld MR, Dalmau J. Diagnosis and management of paraneoplastic neurologic disorders. Current Treatment Options in Oncology. 14: 528-38. PMID 23900965 DOI: 10.1007/S11864-013-0249-1 |
0.41 |
|
| 2013 |
Peereboom DM, Ahluwalia MS, Ye X, Supko JG, Hilderbrand SL, Phuphanich S, Nabors LB, Rosenfeld MR, Mikkelsen T, Grossman SA. NABTT 0502: a phase II and pharmacokinetic study of erlotinib and sorafenib for patients with progressive or recurrent glioblastoma multiforme. Neuro-Oncology. 15: 490-6. PMID 23328813 DOI: 10.1093/Neuonc/Nos322 |
0.304 |
|
| 2013 |
Titulaer MJ, McCracken L, Gabilondo I, Armangué T, Glaser C, Iizuka T, Honig LS, Benseler SM, Kawachi I, Martinez-Hernandez E, Aguilar E, Gresa-Arribas N, Ryan-Florance N, Torrents A, Saiz A, ... Rosenfeld MR, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. The Lancet. Neurology. 12: 157-65. PMID 23290630 DOI: 10.1016/S1474-4422(12)70310-1 |
0.359 |
|
| 2013 |
Boronat A, Gelfand JM, Gresa-Arribas N, Jeong HY, Walsh M, Roberts K, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R, Graus F, Rudy B, Dalmau J. Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels. Annals of Neurology. 73: 120-8. PMID 23225603 DOI: 10.1002/Ana.23756 |
0.409 |
|
| 2012 |
Rosenfeld MR, Titulaer MJ, Dalmau J. Paraneoplastic syndromes and autoimmune encephalitis: Five new things. Neurology. Clinical Practice. 2: 215-223. PMID 23634368 DOI: 10.1212/CPJ.0b013e31826af23e |
0.305 |
|
| 2012 |
Rosenfeld MR, Dalmau J. Paraneoplastic Neurologic Disorders: A Brief Overview. Memo. 5: 197-200. PMID 23264806 DOI: 10.1007/S12254-012-0034-Z |
0.396 |
|
| 2012 |
Nabors LB, Mikkelsen T, Hegi ME, Ye X, Batchelor T, Lesser G, Peereboom D, Rosenfeld MR, Olsen J, Brem S, Fisher JD, Grossman SA. A safety run-in and randomized phase 2 study of cilengitide combined with chemoradiation for newly diagnosed glioblastoma (NABTT 0306). Cancer. 118: 5601-7. PMID 22517399 DOI: 10.1002/Cncr.27585 |
0.333 |
|
| 2012 |
Grossman SA, Ye X, Peereboom D, Rosenfeld MR, Mikkelsen T, Supko JG, Desideri S. Phase I study of terameprocol in patients with recurrent high-grade glioma. Neuro-Oncology. 14: 511-7. PMID 22323663 DOI: 10.1093/Neuonc/Nor230 |
0.32 |
|
| 2012 |
Martinez-Garcia M, Rosenfeld MR. Recent developments in the treatment of high-grade gliomas Community Oncology. 9: 307-314. DOI: 10.1016/J.Cmonc.2012.09.007 |
0.326 |
|
| 2011 |
Nabors LB, Supko JG, Rosenfeld M, Chamberlain M, Phuphanich S, Batchelor T, Desideri S, Ye X, Wright J, Gujar S, Grossman SA. Phase I trial of sorafenib in patients with recurrent or progressive malignant glioma Neuro-Oncology. 13: 1324-1330. PMID 21954442 DOI: 10.1093/Neuonc/Nor145 |
0.311 |
|
| 2011 |
Dalmau J, Rosenfeld MR. Paraneoplastic syndromes causing movement disorders. Handbook of Clinical Neurology. 100: 315-21. PMID 21496591 DOI: 10.1016/B978-0-444-52014-2.00024-0 |
0.377 |
|
| 2011 |
Rosenfeld MR, Dalmau J. Anti-NMDA-Receptor Encephalitis and Other Synaptic Autoimmune Disorders. Current Treatment Options in Neurology. 13: 324-32. PMID 21298406 DOI: 10.1007/S11940-011-0116-Y |
0.383 |
|
| 2011 |
Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. The Lancet. Neurology. 10: 63-74. PMID 21163445 DOI: 10.1016/S1474-4422(10)70253-2 |
0.414 |
|
| 2011 |
Arratibel-Echarren I, Albright K, Dalmau J, Rosenfeld MR. Use of Bevacizumab for neurological complications during initial treatment of malignant gliomas | Utilización de bevacizumab en las complicaciones neurológicas durante el tratamiento inicial de los gliomas malignos Neurologia. 26: 74-80. PMID 21163238 DOI: 10.1016/J.Nrl.2010.05.010 |
0.358 |
|
| 2011 |
Arratibel-Echarren I, Albright K, Dalmau J, Rosenfeld MR. Use of Bevacizumab for neurological complications during initial treatment of malignant gliomas Neurologia. 26: 74-80. DOI: 10.1016/S2173-5808(11)70017-7 |
0.356 |
|
| 2011 |
Rosenfeld MR, Albright K, Pruitt AA. Treatment of recurrent high-grade gliomas Community Oncology. 8: 171-177. DOI: 10.1016/S1548-5315(12)70068-2 |
0.302 |
|
| 2010 |
González-Valcárcel J, Rosenfeld MR, Dalmau J. Differential diagnosis of encephalitis due to anti-NMDA receptor antibodies Neurologia. 25: 409-413. PMID 20964986 DOI: 10.1016/S2173-5808(10)70077-8 |
0.396 |
|
| 2010 |
Rosenfeld MR, Chamberlain MC, Grossman SA, Peereboom DM, Lesser GJ, Batchelor TT, Desideri S, Salazar AM, Ye X. A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastoma. Neuro-Oncology. 12: 1071-7. PMID 20615924 DOI: 10.1093/Neuonc/Noq071 |
0.368 |
|
| 2010 |
Rosenfeld MR, Dalmau J. Update on paraneoplastic and autoimmune disorders of the central nervous system. Seminars in Neurology. 30: 320-31. PMID 20577938 DOI: 10.1055/S-0030-1255223 |
0.409 |
|
| 2010 |
Rosenfeld MR, Dalmau J. Update on paraneoplastic neurologic disorders. The Oncologist. 15: 603-17. PMID 20479279 DOI: 10.1634/Theoncologist.2010-0001 |
0.337 |
|
| 2010 |
Grossman SA, Ye X, Piantadosi S, Desideri S, Nabors LB, Rosenfeld M, Fisher J. Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 2443-9. PMID 20371685 DOI: 10.1158/1078-0432.Ccr-09-3106 |
0.329 |
|
| 2009 |
Nabors LB, Mikkelsen T, Batchelor T, Lesser G, Rosenfeld M, Ye X, Piantadosi S, Olson J, Brem S, Grossman S. NABTT 0306: A randomized phase II trial of EMD 121974 in conjunction with concomitant and adjuvant temozolomide with radiation therapy in patients with newly diagnosed glioblastoma multiforme (GBM). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 2001. PMID 27964566 DOI: 10.1200/Jco.2009.27.15_Suppl.2001 |
0.313 |
|
| 2009 |
Rosenfeld MR, Chamberlain M, Grossman SA, Peereboom DM, Lesser GJ, Batchelor TT, Desideri S, Salazar AM, Ye X. A phase II study of chemoradiation followed by adjuvant temozolomide and poly-ICLC in patients with newly diagnosed glioblastoma: 12- and 18-month survival data (NABTT 0501). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 2002. PMID 27964563 DOI: 10.1200/Jco.2009.27.15_Suppl.2002 |
0.32 |
|
| 2009 |
Tüzün E, Zhou L, Baehring JM, Bannykh S, Rosenfeld MR, Dalmau J. Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma. Acta Neuropathologica. 118: 737-43. PMID 19680671 DOI: 10.1007/S00401-009-0582-4 |
0.412 |
|
| 2009 |
Florance NR, Davis RL, Lam C, Szperka C, Zhou L, Ahmad S, Campen CJ, Moss H, Peter N, Gleichman AJ, Glaser CA, Lynch DR, Rosenfeld MR, Dalmau J. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Annals of Neurology. 66: 11-8. PMID 19670433 DOI: 10.1002/Ana.21756 |
0.342 |
|
| 2008 |
Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, Dessain SK, Rosenfeld MR, Balice-Gordon R, Lynch DR. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. The Lancet. Neurology. 7: 1091-8. PMID 18851928 DOI: 10.1016/S1474-4422(08)70224-2 |
0.416 |
|
| 2008 |
Dalmau J, Rosenfeld MR. Paraneoplastic syndromes of the CNS. The Lancet. Neurology. 7: 327-40. PMID 18339348 DOI: 10.1016/S1474-4422(08)70060-7 |
0.338 |
|
| 2008 |
Rosenfeld MR, Dalmau J. Paraneoplastic syndromes of the nervous system Cancer Neurology in Clinical Practice: Neurologic Complications of Cancer and Its Treatment: Second Edition. 237-255. DOI: 10.1007/978-1-59745-412-4_15 |
0.354 |
|
| 2007 |
Kranick SM, Mowry EM, Rosenfeld MR. Progressive multifocal leukoencephalopathy after rituximab in a case of non-Hodgkin lymphoma. Neurology. 69: 704-6. PMID 17698796 DOI: 10.1212/01.Wnl.0000267325.06000.D9 |
0.317 |
|
| 2007 |
Dalmau J, Tüzün E, Wu HY, Masjuan J, Rossi JE, Voloschin A, Baehring JM, Shimazaki H, Koide R, King D, Mason W, Sansing LH, Dichter MA, Rosenfeld MR, Lynch DR. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Annals of Neurology. 61: 25-36. PMID 17262855 DOI: 10.1002/Ana.21050 |
0.433 |
|
| 2007 |
Mathew RM, Vandenberghe R, Garcia-Merino A, Yamamoto T, Landolfi JC, Rosenfeld MR, Rossi JE, Thiessen B, Dropcho EJ, Dalmau J. Orchiectomy for suspected microscopic tumor in patients with anti-Ma2-associated encephalitis Neurology. 68: 900-905. PMID 17151337 DOI: 10.1212/01.Wnl.0000252379.81933.80 |
0.405 |
|
| 2007 |
Nabors LB, Rosenfeld M, Chamberlain M, Phuphanich S, Batchelor T, Supko J, Desideri S, Xiaobu Y, Wright J, Grossman S. A phase I trial of sorafenib (BAY 43-9006) for patients with recurrent or progressive malignant glioma (NABTT 0401) Journal of Clinical Oncology. 25: 2058-2058. DOI: 10.1200/Jco.2007.25.18_Suppl.2058 |
0.324 |
|
| 2007 |
Bataller L, Kleopa KA, Wu GF, Rossi JE, Rosenfeld MR, Dalmau J. Autoimmune limbic encephalitis in 39 patients: Immunophenotypes and outcomes Journal of Neurology, Neurosurgery and Psychiatry. 78: 381-385. DOI: 10.1136/Jnnp.2006.100644 |
0.423 |
|
| 2007 |
Rosenfeld MR, Dalmau J. Paraneoplastic limbic encephalitis associated with small-cell lung cancer Community Oncology. 4: 491-494. DOI: 10.1016/S1548-5315(11)70483-1 |
0.38 |
|
| 2007 |
Rosenfeld MR, Pruitt AA. Managing medical complications in patients with brain tumors Community Oncology. 4: 411-416. DOI: 10.1016/S1548-5315(11)70149-8 |
0.315 |
|
| 2006 |
Rosenfeld MR, Dalmau J. Current therapies for neuromuscular manifestations of paraneoplastic syndromes. Current Neurology and Neuroscience Reports. 6: 77-84. PMID 16469274 DOI: 10.1007/S11910-996-0012-0 |
0.404 |
|
| 2005 |
Ances BM, Vitaliani R, Taylor RA, Liebeskind DS, Voloschin A, Houghton DJ, Galetta SL, Dichter M, Alavi A, Rosenfeld MR, Dalmau J. Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain : a Journal of Neurology. 128: 1764-77. PMID 15888538 DOI: 10.1093/Brain/Awh526 |
0.429 |
|
| 2004 |
Dalmau J, Graus F, Villarejo A, Posner JB, Blumenthal D, Thiessen B, Saiz A, Meneses P, Rosenfeld MR. Clinical analysis of anti-Ma2-associated encephalitis. Brain : a Journal of Neurology. 127: 1831-44. PMID 15215214 DOI: 10.1093/Brain/Awh203 |
0.42 |
|
| 2004 |
Bataller L, Wade DF, Graus F, Stacey HD, Rosenfeld MR, Dalmau J. Antibodies to Zic4 in paraneoplastic neurologic disorders and small-cell lung cancer Neurology. 62: 778-782. PMID 15007130 DOI: 10.1212/01.Wnl.0000113749.77217.01 |
0.434 |
|
| 2003 |
Bataller L, Rosenfeld MR, Graus F, Vilchez JJ, Cheung NK, Dalmau J. Autoantigen diversity in the opsoclonus-myoclonus syndrome. Annals of Neurology. 53: 347-53. PMID 12601702 DOI: 10.1002/Ana.10462 |
0.377 |
|
| 2003 |
Rosenfeld MR, Dalmau J. Current Therapies for Paraneoplastic Neurologic Syndromes. Current Treatment Options in Neurology. 5: 69-77. PMID 12521564 DOI: 10.1007/S11940-003-0023-Y |
0.399 |
|
| 2003 |
Bataller L, Wade DF, Graus F, Rosenfeld MR, Dalmau J. The MAZ protein is an autoantigen of Hodgkin's disease and paraneoplastic cerebellar dysfunction. Annals of Neurology. 53: 123-7. PMID 12509857 DOI: 10.1002/Ana.10434 |
0.374 |
|
| 2002 |
Bataller L, Wade DF, Fuller GN, Rosenfeld MR, Dalmau J. Cerebellar degeneration and autoimmunity to zinc-finger proteins of the cerebellum. Neurology. 59: 1985-7. PMID 12499499 DOI: 10.1212/01.Wnl.0000038352.01415.Ce |
0.343 |
|
| 2001 |
Rosenfeld MR, Dalmau J. The clinical spectrum and pathogenesis of paraneoplastic disorders of the central nervous system Hematology/Oncology Clinics of North America. 15: 1109-1128. PMID 11770301 DOI: 10.1016/S0889-8588(05)70270-7 |
0.357 |
|
| 2001 |
Eichen JG, Dalmau J, Demopoulos A, Wade D, Posner JB, Rosenfeld MR. The photoreceptor cell-specific nuclear receptor is an autoantigen of paraneoplastic retinopathy. Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society. 21: 168-72. PMID 11725181 DOI: 10.1097/00041327-200109000-00003 |
0.711 |
|
| 2001 |
Rosenfeld MR, Eichen JG, Wade DF, Posner JB, Dalmau J. Molecular and clinical diversity in paraneoplastic immunity to Ma proteins. Annals of Neurology. 50: 339-48. PMID 11558790 DOI: 10.1002/Ana.1288 |
0.415 |
|
| 2000 |
Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau J. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain : a Journal of Neurology. 123: 1481-94. PMID 10869059 DOI: 10.1093/Brain/123.7.1481 |
0.417 |
|
| 1999 |
Dalmau J, Gultekin SH, Voltz R, Hoard R, DesChamps T, Balmaceda C, Batchelor T, Gerstner E, Eichen J, Frennier J, Posner JB, Rosenfeld MR. Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders. Brain : a Journal of Neurology. 122: 27-39. PMID 10050892 DOI: 10.1093/Brain/122.1.27 |
0.439 |
|
| 1999 |
Voltz R, Carpentier AF, Rosenfeld MR, Posner JB, Dalmau J. P/Q-type voltage-gated calcium channel antibodies in paraneoplastic disorders of the central nervous system. Muscle & Nerve. 22: 119-22. PMID 9883867 DOI: 10.1002/(Sici)1097-4598(199901)22:1<119::Aid-Mus19>3.0.Co;2-5 |
0.395 |
|
| 1998 |
Khakoo Y, Rosenfeld MR. Understanding regulation of cell growth in childhood brain tumors Current Opinion in Pediatrics. 10: 551-555. PMID 9848011 DOI: 10.1097/00008480-199810060-00002 |
0.3 |
|
| 1998 |
Voltz R, Dalmau J, Posner JB, Rosenfeld MR. T-cell receptor analysis in anti-Hu associated paraneoplastic encephalomyelitis. Neurology. 51: 1146-50. PMID 9781545 DOI: 10.1212/Wnl.51.4.1146 |
0.374 |
|
| 1998 |
Levin MC, Krichavsky M, Berk J, Foley S, Rosenfeld M, Dalmau J, Chang G, Posner JB, Jacobson S. Neuronal molecular mimicry in immune-mediated neurologic disease. Annals of Neurology. 44: 87-98. PMID 9667596 DOI: 10.1002/Ana.410440115 |
0.391 |
|
| 1998 |
Degenhardt A, Duvoisin RM, Frennier J, Gultekin SH, Rosenfeld MR, Posner JB, Dalmau J. Absence of antibodies to non-NMDA glutamate-receptor subunits in paraneoplastic cerebellar degeneration. Neurology. 50: 1392-7. PMID 9595993 DOI: 10.1212/Wnl.50.5.1392 |
0.408 |
|
| 1998 |
Verschuuren JJ, Dalmau J, Tunkel R, Lang B, Graus F, Schramm L, Posner JB, Newsom-Davis J, Rosenfeld MR. Antibodies against the calcium channel beta-subunit in Lambert-Eaton myasthenic syndrome. Neurology. 50: 475-9. PMID 9484375 DOI: 10.1212/Wnl.50.2.475 |
0.348 |
|
| 1997 |
Mason WP, Graus F, Lang B, Honnorat J, Delattre JY, Valldeoriola F, Antoine JC, Rosenblum MK, Rosenfeld MR, Newsom-Davis J, Posner JB, Dalmau J. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain : a Journal of Neurology. 120: 1279-300. PMID 9278623 DOI: 10.1093/Brain/120.8.1279 |
0.405 |
|
| 1997 |
Rosenfeld MR, Malats N, Schramm L, Graus F, Cardenal F, Viñolas N, Rosell R, Torà M, Real FX, Posner JB, Dalmau J. Serum anti-p53 antibodies and prognosis of patients with small-cell lung cancer. Journal of the National Cancer Institute. 89: 381-5. PMID 9060960 DOI: 10.1093/Jnci/89.5.381 |
0.385 |
|
| 1996 |
Morita M, Rosenblum MK, Bilsky MH, Fraser RA, Rosenfeld MR. Long-term survivors of glioblastoma multiforme: clinical and molecular characteristics. Journal of Neuro-Oncology. 27: 259-66. PMID 8847560 DOI: 10.1007/Bf00165483 |
0.318 |
|
| 1995 |
Dalmau J, Rosenfeld MR. [16] Characterization of neuronal antigens and antineuronal antibodies Methods in Neurosciences. 24: 261-271. DOI: 10.1016/S1043-9471(06)80154-0 |
0.398 |
|
| 1991 |
Szabo A, Dalmau J, Manley G, Rosenfeld M, Wong E, Henson J, Posner JB, Furneaux HM. HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal. Cell. 67: 325-33. PMID 1655278 DOI: 10.1016/0092-8674(91)90184-Z |
0.378 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2007 |
Mathew RM, Rosenfeld MR. Neurologic Complications of Bone Marrow and Stem-cell Transplantation in Patients with Cancer. Current Treatment Options in Neurology. 9: 308-14. PMID 17580010 DOI: 10.1007/S11940-007-0016-3 |
0.3 |
|
| 2006 |
Pruitt A, Dalmau J, Detre J, Alavi A, Rosenfeld MR. Episodic neurologic dysfunction with migraine and reversible imaging findings after radiation. Neurology. 67: 676-8. PMID 16707725 DOI: 10.1212/01.Wnl.0000228862.76269.62 |
0.298 |
|
| 1995 |
Liu J, Dalmau J, Szabo A, Rosenfeld M, Huber J, Furneaux H. Paraneoplastic Encephalomyelitis Antigens Bind to the AU-rich Elements of mRNA Neurology. 45: 544-550. PMID 7898713 DOI: 10.1212/Wnl.45.3.544 |
0.297 |
|
| 2010 |
Rosenfeld MR, Grossman SA, Brem S, Mikkelsen T, Wang D, Piao S, Davis LE, O'Dwyer PJ, Amaravadi RK. Pharmacokinetic analysis and pharmacodynamic evidence of autophagy inhibition in patients with newly diagnosed glioblastoma treated on a phase I trial of hydroxychloroquine in combination with adjuvant temozolomide and radiation (ABTC 0603). Journal of Clinical Oncology. 28: 3086-3086. DOI: 10.1200/Jco.2010.28.15_Suppl.3086 |
0.294 |
|
| 2015 |
Woehrer A, Lau CC, Prayer D, Bauchet L, Rosenfeld M, Capper D, Fisher PG, Kool M, Müller M, Kros JM, Kruchko C, Wiemels J, Wrensch M, Danysh HE, Zouaoui S, et al. Brain Tumor Epidemiology - A Hub within Multidisciplinary Neuro-oncology. Report on the 15th Brain Tumor Epidemiology Consortium (BTEC) Annual Meeting, Vienna, 2014. Clinical Neuropathology. 34: 40-6. PMID 25518914 DOI: 10.5414/Np300846 |
0.293 |
|
| 2000 |
Gromeier M, Lachmann S, Rosenfeld MR, Gutin PH, Wimmer E. Intergeneric poliovirus recombinants for the treatment of malignant glioma. Proceedings of the National Academy of Sciences of the United States of America. 97: 6803-8. PMID 10841575 DOI: 10.1073/Pnas.97.12.6803 |
0.292 |
|
| 2008 |
Rosenfeld MR, Chamberlain MC, Grossman SA, Peereboom DM, Lesser GJ, Batchelor TT, Desideri S, Salazar AM, Ye X. A phase II trial of radiation plus temozolomide followed by adjuvant temozolomide and poly-ICLC in patients with newly diagnosed glioblastoma multiforme (NABTT #0501). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 2055. PMID 27948099 DOI: 10.1200/Jco.2008.26.15_Suppl.2055 |
0.292 |
|
| 2015 |
Leypoldt F, Höftberger R, Titulaer MJ, Armangue T, Gresa-Arribas N, Jahn H, Rostásy K, Schlumberger W, Meyer T, Wandinger KP, Rosenfeld MR, Graus F, Dalmau J. Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response. Jama Neurology. 72: 180-6. PMID 25436993 DOI: 10.1001/Jamaneurol.2014.2956 |
0.288 |
|
| 2009 |
Carpenter EL, Mick R, Rech AJ, Beatty GL, Colligon TA, Rosenfeld MR, Kaplan DE, Chang KM, Domchek SM, Kanetsky PA, Fecher LA, Flaherty KT, Schuchter LM, Vonderheide RH. Collapse of the CD27+ B-cell compartment associated with systemic plasmacytosis in patients with advanced melanoma and other cancers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 4277-87. PMID 19549767 DOI: 10.1158/1078-0432.Ccr-09-0537 |
0.285 |
|
| 1997 |
Rosenfeld MR, Bergman I, Schramm L, Griffin JA, Kaplitt MG, Meneses PI. Adeno-associated viral vector gene transfer into leptomeningeal xenografts. Journal of Neuro-Oncology. 34: 139-44. PMID 9210060 DOI: 10.1023/A:1005702228721 |
0.285 |
|
| 2009 |
Grossman SA, Ye X, Piantadosi S, Desideri S, Nabors LB, Rosenfeld M, Fisher J. Current survival statistics for patients with newly diagnosed glioblastoma treated with radiation and temozolomide on research studies in the United States. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 2003. PMID 27964564 DOI: 10.1200/Jco.2009.27.15_Suppl.2003 |
0.283 |
|
| 2003 |
Fisher PB, Gopalkrishnan RV, Chada S, Ramesh R, Grimm EA, Rosenfeld MR, Curiel DT, Dent P. mda-7/IL-24, a novel cancer selective apoptosis inducing cytokine gene: from the laboratory into the clinic. Cancer Biology & Therapy. 2: S23-37. PMID 14508078 DOI: 10.4161/Cbt.458 |
0.282 |
|
| 1995 |
Rosenfeld MR, Meneses P, Dalmau J, Drobnjak M, Cordon-Cardo C, Kaplitt MG. Gene transfer of wild-type p53 results in restoration of tumor-suppressor function in a medulloblastoma cell line. Neurology. 45: 1533-9. PMID 7644054 DOI: 10.1212/Wnl.45.8.1533 |
0.282 |
|
| 2009 |
Fiveash JB, Chowdhary SA, Peereboom D, Mikkelsen T, Nabors LB, Lesser GJ, Rosenfeld MR, Ye X, Grossman SA. NABTT-0702: A phase II study of R-(-)-gossypol (AT-101) in recurrent glioblastoma multiforme (GBM). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 2010. PMID 27964593 DOI: 10.1200/Jco.2009.27.15_Suppl.2010 |
0.281 |
|
| 2011 |
Sanborn MR, Danish SF, Rosenfeld MR, O'Rourke D, Lee JY. Treatment of steroid refractory, Gamma Knife related radiation necrosis with bevacizumab: case report and review of the literature. Clinical Neurology and Neurosurgery. 113: 798-802. PMID 21906869 DOI: 10.1016/J.Clineuro.2011.08.007 |
0.281 |
|
| 2010 |
Blakeley JO, Ye X, Grossman SA, Mikkelsen T, Rosenfeld MR, Bradley CR, Eichler AF, Nabors LB, Desideri S, Supko JG. Poly (ADP-ribose) polymerase-1 (PARP1) inhibitor BSI-201 in combination with temozolomide (TMZ) in malignant glioma. Journal of Clinical Oncology. 28: 2012-2012. DOI: 10.1200/Jco.2010.28.15_Suppl.2012 |
0.28 |
|
| 2006 |
Rosenfeld MR, Pruitt A. Neurologic complications of bone marrow, stem cell, and organ transplantation in patients with cancer. Seminars in Oncology. 33: 352-61. PMID 16769425 DOI: 10.1053/J.Seminoncol.2006.03.003 |
0.279 |
|
| 2007 |
Whitmore RG, Krejza J, Kapoor GS, Huse J, Woo JH, Bloom S, Lopinto J, Wolf RL, Judy K, Rosenfeld MR, Biegel JA, Melhem ER, O'Rourke DM. Prediction of oligodendroglial tumor subtype and grade using perfusion weighted magnetic resonance imaging. Journal of Neurosurgery. 107: 600-9. PMID 17886561 DOI: 10.3171/Jns-07/09/0600 |
0.277 |
|
| 2006 |
Phuphanich S, Supko J, Carson KA, Grossman SA, Nabors LB, Mikkelsen T, Lesser G, Rosenfeld M, Desideri S, Olson J. Phase I trial of bortezomib in adults with recurrent malignant glioma Journal of Clinical Oncology. 24: 1567-1567. DOI: 10.1200/Jco.2006.24.18_Suppl.1567 |
0.275 |
|
| 2004 |
Yacoub A, Mitchell C, Hong Y, Gopalkrishnan RV, Su ZZ, Gupta P, Sauane M, Lebedeva IV, Curiel DT, Mahasreshti PJ, Rosenfeld MR, Broaddus WC, James CD, Grant S, Fisher PB, et al. MDA-7 regulates cell growth and radiosensitivity in vitro of primary (non-established) human glioma cells. Cancer Biology & Therapy. 3: 739-51. PMID 15197348 DOI: 10.4161/Cbt.3.8.968 |
0.275 |
|
| 2005 |
Pruitt AA, Rosenfeld MR. 10 questions about temozolomide and the treatment of brain tumors. The Neurologist. 11: 362-5. PMID 16286879 DOI: 10.1097/01.Nrl.0000186862.77459.01 |
0.274 |
|
| 2013 |
Pruitt AA, Graus F, Rosenfeld MR. Neurological complications of solid organ transplantation. The Neurohospitalist. 3: 152-66. PMID 24167649 DOI: 10.1177/1941874412466090 |
0.272 |
|
| 2017 |
Parasramka S, Talari G, Villano JL, Rosenfeld M, Guo J. Procarbazine, lomustine and vincristine for recurrent high-grade glioma. The Cochrane Database of Systematic Reviews. 7: CD011773. PMID 28744879 DOI: 10.1002/14651858.Cd011773.Pub2 |
0.269 |
|
| 2013 |
Norden AD, Lesser GJ, Drappatz J, Ligon KL, Hammond SN, Lee EQ, Reardon DR, Fadul CE, Plotkin SR, Batchelor TT, Zhu JJ, Beroukhim R, Muzikansky A, Doherty L, Lafrankie D, ... ... Rosenfeld MR, et al. Phase 2 study of dose-intense temozolomide in recurrent glioblastoma. Neuro-Oncology. 15: 930-5. PMID 23553268 DOI: 10.1200/Jco.2011.29.15_Suppl.2038 |
0.266 |
|
| 1992 |
Schlegel U, Rosenfeld MR, Volkenandt M, Rosenblum M, Dalmau J, Furneaux H. p53 gene mutations in primary lung tumors are conserved in brain metastases Journal of Neuro-Oncology. 14: 93-100. PMID 1331352 DOI: 10.1007/Bf00177612 |
0.265 |
|
| 2009 |
Gasparetto EL, Pawlak MA, Patel SH, Huse J, Woo JH, Krejza J, Rosenfeld MR, O'Rourke DM, Lustig R, Melhem ER, Wolf RL. Posttreatment recurrence of malignant brain neoplasm: accuracy of relative cerebral blood volume fraction in discriminating low from high malignant histologic volume fraction. Radiology. 250: 887-96. PMID 19244052 DOI: 10.1148/Radiol.2502071444 |
0.265 |
|
| 2007 |
Rosenfeld MR, Dalmau J. Chapter 101 – Paraneoplastic Disorders Of The Nervous System Neurology and Clinical Neuroscience. 1361-1374. DOI: 10.1016/B978-0-323-03354-1.50105-X |
0.264 |
|
| 2012 |
Rosenfeld MR, Dalmau J. Immune-Mediated Paraneoplastic Neurologic Disorders: An Overview Neuro-Oncology: First Edition. 213-222. DOI: 10.1002/9781118321478.ch20 |
0.26 |
|
| 2018 |
Rosenfeld MR, Dalmau J. Paraneoplastic Neurologic Syndromes. Neurologic Clinics. 36: 675-685. PMID 30072076 DOI: 10.1016/j.ncl.2018.04.015 |
0.257 |
|
| 2010 |
Dalmau J, Rosenfeld MR. Update on paraneoplastic neurologic disorders. Community Oncology. 7: 219-224. PMID 21572897 |
0.257 |
|
| 1978 |
Makman MH, Ahn HS, Thal LJ, Dvorkin B, Horowitz SG, Sharpless NS, Rosenfeld M. Biogenic amine-stimulated adenylate cyclase and spiroperidol-binding sites in rabbit brain: evidence for selective loss of receptors with aging. Advances in Experimental Medicine and Biology. 113: 211-30. PMID 753089 DOI: 10.1007/978-1-4684-8893-7_13 |
0.257 |
|
| 2015 |
Blakeley JO, Grossman SA, Mikkelsen T, Rosenfeld MR, Peereboom D, Nabors LB, Chi AS, Emmons G, Ribas IG, Supko JG, Desideri S, Ye X. Phase I study of iniparib concurrent with monthly or continuous temozolomide dosing schedules in patients with newly diagnosed malignant gliomas. Journal of Neuro-Oncology. PMID 26285766 DOI: 10.1007/S11060-015-1876-0 |
0.256 |
|
| 1993 |
Rosenfeld MR, Wong E, Dalmau J, Manley G, Egan D, Posner JB, Sher E, Furneaux HM. Sera from patients with Lambert-Eaton myasthenic syndrome recognize the beta-subunit of Ca2+ channel complexes. Annals of the New York Academy of Sciences. 681: 408-11. PMID 8395157 DOI: 10.1111/J.1749-6632.1993.Tb22922.X |
0.246 |
|
| 2022 |
Joubert B, Petit-Pedrol M, Planagumà J, Mannara F, Radosevic M, Marsal M, Maudes E, García-Serra A, Aguilar E, Andrés-Bilbé A, Gasull X, Loza-Alvarez P, Sabater L, Rosenfeld MR, Dalmau J. Human CASPR2 Antibodies Reversibly Alter Memory and the CASPR2 Protein Complex. Annals of Neurology. PMID 35253937 DOI: 10.1002/ana.26345 |
0.242 |
|
| 1980 |
Goldstein M, Lieberman A, Lew JY, Asano T, Rosenfeld MR, Makman MH. Interaction of pergolide with central dopaminergic receptors Proceedings of the National Academy of Sciences of the United States of America. 77: 3725-3728. PMID 6932044 DOI: 10.1073/Pnas.77.6.3725 |
0.241 |
|
| 2008 |
Rosenfeld MR. Malignancy and neurofibromatosis type 1: Balancing treatment risks/benefits and expected prognosis Community Oncology. 5: 546. DOI: 10.1016/S1548-5315(11)70510-1 |
0.238 |
|
| 2018 |
Armangue T, Spatola M, Vlagea A, Mattozzi S, Cárceles-Cordon M, Martinez-Heras E, Llufriu S, Muchart J, Erro ME, Abraira L, Moris G, Monros-Giménez L, Corral-Corral Í, Montejo C, Toledo M, ... ... Rosenfeld MR, et al. Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis. The Lancet. Neurology. PMID 30049614 DOI: 10.1016/S1474-4422(18)30244-8 |
0.236 |
|
| 1980 |
Makman MH, Ahn HS, Thal LJ, Sharpless NS, Dvorkin B, Horowitz SG, Rosenfeld M. Evidence for selective loss of brain dopamine- and histamine-stimulated adenylate cyclase activities in rabbits with aging. Brain Research. 192: 177-83. PMID 7378778 DOI: 10.1016/0006-8993(80)91017-3 |
0.233 |
|
| 1993 |
Rosenfeld MR, Dalmau J. Paraneoplastic syndromes and progressive motor dysfunction Seminars in Neurology. 13: 291-298. PMID 8272601 DOI: 10.1055/S-2008-1041137 |
0.232 |
|
| 2012 |
Rosenfeld MR, Dalmau J. Central nervous system paraneoplastic disease. Handbook of Clinical Neurology. 105: 853-64. PMID 22230537 DOI: 10.1016/B978-0-444-53502-3.00027-6 |
0.23 |
|
| 1998 |
Carpentier AF, Voltz R, DesChamps T, Posner JB, Dalmau J, Rosenfeld MR. Absence of HuD gene mutations in paraneoplastic small cell lung cancer tissue. Neurology. 50: 1919. PMID 9633765 DOI: 10.1212/Wnl.50.6.1919 |
0.23 |
|
| 1998 |
Carpentier AF, Rosenfeld MR, Delattre JY, Whalen RG, Posner JB, Dalmau J. DNA vaccination with HuD inhibits growth of a neuroblastoma in mice. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 4: 2819-24. PMID 9829748 |
0.229 |
|
| 2006 |
Rosenfeld MR. A reflection of progress and hope Community Oncology. 3: 116. DOI: 10.1016/S1548-5315(11)70664-7 |
0.227 |
|
| 1982 |
Rosenfeld MR, Dvorkin B, Klein PN, Makman MH. Differential affinities of molindone, metoclopramide and domperidone for classes of [3H]spiroperidol binding sites in rat striatum: evidence for pharmacologically distinct classes of receptors Brain Research. 235: 205-211. PMID 6145486 DOI: 10.1016/0006-8993(82)90214-1 |
0.225 |
|
| 2006 |
Rosenfeld MR. Should radiotherapy for low-grade glioma be given immediately after surgery or at the time of progression? Nature Clinical Practice. Neurology. 2: 128-9. PMID 16932536 DOI: 10.1038/Ncpneuro0128 |
0.223 |
|
| 2006 |
Rosenfeld MR. Inroads in managing malignant gliomas renew hope Community Oncology. 3: 684. DOI: 10.1016/S1548-5315(11)70922-6 |
0.221 |
|
| 1993 |
Rosenfeld MR, Wong E, Dalmau J, Manley G, Posner JB, Sher E, Furneaux HM. Cloning and characterization of a Lambert-Eaton myasthenic syndrome antigen. Annals of Neurology. 33: 113-20. PMID 8494331 DOI: 10.1002/ana.410330126 |
0.22 |
|
| 1980 |
Rosenfeld MR, Makman MH, Goldstein M. Stimulation of adenylate cyclase in rat striatum by pergolide: influence of GTP European Journal of Pharmacology. 68: 65-68. PMID 7449835 DOI: 10.1016/0014-2999(80)90062-X |
0.219 |
|
| 2012 |
Rosenfeld MR, Dalmau JO. Paraneoplastic disorders of the CNS and autoimmune synaptic encephalitis. Continuum (Minneapolis, Minn.). 18: 366-83. PMID 22810133 DOI: 10.1212/01.CON.0000413664.42798.aa |
0.213 |
|
| 1996 |
Vogt L, Giger RJ, Ziegler U, Kunz B, Buchstaller A, Hermens WTJMC, Kaplitt MG, Rosenfeld MR, Pfaff DW, Verhaagen J, Sonderegger P. Continuous renewal of the axonal pathway sensor apparatus by insertion of new sensor molecules into the growth cone membrane. Current Biology : Cb. 6: 1153-8. PMID 8805367 DOI: 10.1016/S0960-9822(02)70682-9 |
0.203 |
|
| 2010 |
López MEN, Gómez-Ibáñez A, Rosenfeld M, Dalmau J. Gliomatosis cerebral: estudio de 22 pacientes Neurologia. 25: 168-173. DOI: 10.1016/S0213-4853(10)70005-0 |
0.201 |
|
| 2007 |
Sandborn WJ, Rutgeerts P, Enns R, Hanauer SB, Colombel JF, Panaccione R, D'Haens G, Li J, Rosenfeld MR, Kent JD, Pollack PF. Adalimumab induction therapy for Crohn disease previously treated with infliximab: A randomized trial Annals of Internal Medicine. 146: 829-838. PMID 17470824 |
0.2 |
|
| 1979 |
Rosenfeld MR, Seeger TF, Sharpless NS, Gardner EL, Makman MH. Denervation supersensitivity in the mesolimbic system: involvement of dopamine-stimulated adenylate cyclase Brain Research. 173: 572-576. PMID 487111 DOI: 10.1016/0006-8993(79)90255-5 |
0.191 |
|
| 1999 |
Voltz R, Gultekin SH, Rosenfeld MR, Gerstner E, Eichen J, Posner JB, Dalmau J. A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer. The New England Journal of Medicine. 340: 1788-95. PMID 10362822 DOI: 10.1056/NEJM199906103402303 |
0.19 |
|
| 2012 |
Rosenfeld MR, Dalmau J. Paraneoplastic neurological disorders in leukemia and lymphoma Lymphoma and Leukemia of the Nervous System. 329-344. DOI: 10.1007/9781441976680_20 |
0.187 |
|
| 2013 |
Villano JL, Wen PY, Lee EQ, Nayak L, Reardon DA, Rosenfeld MR. PCV for anaplastic oligodendrogliomas: back to the future or a step backwards? A point/counterpoint discussion. Journal of Neuro-Oncology. 113: 143-7. PMID 23479035 DOI: 10.1007/S11060-013-1100-Z |
0.185 |
|
| 2008 |
Martínez-Hernández E, Rosenfeld MR, Pruitt A, Dalmau J. [Neurological complications of transplantation]. Neurología (Barcelona, Spain). 23: 373-86. PMID 18597192 |
0.172 |
|
| 2024 |
Fiveash JB, Ye X, Peerboom DM, Mikkelsen T, Chowdhary S, Rosenfeld M, Lesser GJ, Fisher J, Desideri S, Grossman S, Leopold L, Nabors LB. Clinical trials of R-(-)-gossypol (AT-101) in newly diagnosed and recurrent glioblastoma: NABTT 0602 and NABTT 0702. Plos One. 19: e0291128. PMID 38285688 DOI: 10.1371/journal.pone.0291128 |
0.169 |
|
| 2014 |
Titulaer MJ, Rosenfeld MR, Dalmau J. Reply: To PMID 24700511. Annals of Neurology. 76: 464-5. PMID 25043899 DOI: 10.1002/Ana.24223 |
0.163 |
|
| 1999 |
Meneses PI, Abrey LE, Hajjar KA, Gultekin SH, Duvoisin RM, Berns KI, Rosenfeld MR. Simplified production of a recombinant human angiostatin derivative that suppresses intracerebral glial tumor growth. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 5: 3689-94. PMID 10589788 |
0.15 |
|
| 1998 |
Modak SI, Gultekin SH, Kramer K, Guo HF, Rosenfeld MR, Ladanyi M, Larson SM, Cheung NKV. Novel Tumor-Associated Surface Antigen: Broad Distribution among Neuroectodermal, Mesenchymal and Epithelial Tumors, with Restricted Expression among Normal Tissues † 785 Pediatric Research. 43: 136-136. DOI: 10.1203/00006450-199804001-00806 |
0.148 |
|
| 2013 |
Rosenfeld MR. Bridging science and clinical practice: how to use molecular markers when caring for a patient with brain cancer. American Society of Clinical Oncology Educational Book / Asco. American Society of Clinical Oncology. Meeting. 108-13. PMID 23714471 DOI: 10.1200/EdBook_AM.2013.33.108 |
0.147 |
|
| 2010 |
Rosenfeld MR, Dalmau JO. General Approach to the Diagnosis and Treatment of Paraneoplastic Neurologic Disorders International Neurology: a Clinical Approach. 550-553. DOI: 10.1002/9781444317008.Ch141 |
0.142 |
|
| 1997 |
Rosenfeld MR, Dalmau J. Primary cerebral tumors: The reality and the molecular bases for future treatments Neurologia. 12: 185-196. PMID 9280426 |
0.133 |
|
| 2010 |
Novillo López M, Gómez-Ibáñez A, Rosenfeld M, Dalmau J. Gliomatosis cerebri: Review of 22 patients Neurología (English Edition). 25: 168-173. DOI: 10.1016/S2173-5808(10)70033-X |
0.129 |
|
| 2013 |
Dalmau J, Rosenfeld MR. Paraneoplastic Neurologic Syndromes Abeloff's Clinical Oncology: Fifth Edition. 597-607. DOI: 10.1016/B978-1-4557-2865-7.00039-4 |
0.112 |
|
| 2013 |
Gundogdu B, Rosenfeld MR, Rudnicki SA. Paraneoplastic neuromuscular disorders Neuromuscular Disorders in Clinical Practice. 1501-1514. DOI: 10.1007/978-1-4614-6567-6_75 |
0.112 |
|
| 2010 |
Lai R, Recht LD, Reardon DA, Paleologos N, Groves MD, Rosenfeld MR, Meech S, Davis TA, Pavlov D, Sampson JH. Interim data for ACT III: Phase II trial of PF-04948568 (CDX-110) in combination with temozolomide (TMZ) in patients (pts) with glioblastoma (GBM). Journal of Clinical Oncology. 28: 2014-2014. DOI: 10.1200/JCO.2010.28.15_SUPPL.2014 |
0.107 |
|
| 2017 |
New PZ, Rosenfeld MR. Editorial: Pitfalls in the Neuro-Imaging of Glioblastoma in the Era of Antiangiogenic and Immune-Targeted Therapy-Detecting Elusive Disease, Defining Response. Frontiers in Neurology. 8: 311. PMID 28717352 DOI: 10.3389/fneur.2017.00311 |
0.103 |
|
| 1999 |
Rosenfeld MR, Gutin PH, Dalmau J. Practical aspects in the diagnosis and treatment of cerebral gliomas Neurologia. 14: 111-121. PMID 10232011 |
0.101 |
|
| 2012 |
Rosenfeld MR, Pruitt AA. Management of malignant gliomas and primary CNS lymphoma: standard of care and future directions. Continuum (Minneapolis, Minn.). 18: 406-15. PMID 22810135 DOI: 10.1212/01.CON.0000413666.88539.0b |
0.1 |
|
| 1981 |
Rosenfeld MR, Makman MH. The interaction of lisuride, an ergot derivative, with serotonergic and dopaminergic receptors in rabbit brain Journal of Pharmacology and Experimental Therapeutics. 216: 526-531. PMID 7205633 |
0.082 |
|
| 1980 |
Rosenfeld MR, Makman MH, Ahn HS, Thal LJ, Mishra RK, Katzman R. Selective influence of ergot alkaloids on cortical and striatal dopaminergic and sergotonergic receptors. Advances in Biochemical Psychopharmacology. 23: 83-93. PMID 6249092 |
0.082 |
|
| 1997 |
Moore DF, Rosenfeld MR, Gribbon PM, Winlove CP, Tsai CM. Alpha-1-acid (AAG, Orosomucoid) glycoprotein: Interaction with bacterial lipopolysaccharide and protection from sepsis Inflammation. 21: 69-82. PMID 9179623 DOI: 10.1023/A:1027342909423 |
0.08 |
|
| 1996 |
Gelanze M, Meneses P, Brittis M, Rosenfeld MR, Duvoisin RM, Coleman DJ. Transplantation into the subretinal space of iris pigmented epithelial cells labeled using a lacZ-encoding defective HSV Investigative Ophthalmology and Visual Science. 37: S94. |
0.075 |
|
| 1991 |
Rosenfeld MR, Posner JB. Paraneoplastic motor neuron disease. Advances in Neurology. 56: 445-59. PMID 1853777 |
0.056 |
|
| 2010 |
ROSENFELD M. ASK THE EXPERTS Neurology Now. 6: 39. DOI: 10.1097/01.NNN.0000390000.33588.CB |
0.011 |
|
| 2020 |
Santamaria J, Rosenfeld MR. Take Care. Current Treatment Options in Neurology. 22: 32. PMID 32834713 DOI: 10.1007/s11940-020-00637-1 |
0.01 |
|
| 1998 |
Rosenfeld MR. Contracts: district court holds FEHBA preempted by Pennsylvania statute The Journal of Law, Medicine &Amp; Ethics : a Journal of the American Society of Law, Medicine &Amp; Ethics. 26: 357. PMID 11066898 |
0.01 |
|
| Hide low-probability matches. |